International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: 10.5281/zenodo.13733884
Original Research Article
A Study of Ocular Coherence Tomography (OCT) Findings in Patients Having Different Types of Age-Related Macular Degeneration (ARMD) in Government Hospital, Jamnagar, Gujarat
Published
Sept. 9, 2024
Abstract

Introduction:People over 50 who have ARMD, also known as age-related macular degeneration disorder, suffer from a degenerative disease. Drusen, geographic RPE atrophy, separation of the serous retinal pigment epithelium, and choroidal neovascularization were all symptoms of the disorder. The main factor causing lifelong blindness is ARMD. The forecasted increase is substantial because it is predicted that the population of people 80 and older would increase by 105% in the following ten years. Wet / exudative / neovascular and dry /atrophic / non-neovascular degenerative lesions of the macula are the two categories, clinically speaking. Loss of vision may result from either of these categories. Aim and Objective: Aim of the study is to find out ocular problems in different types of age-related Macular Degeneration (ARMD). Material and Method: It is a hospital based prospective study. After taking into consideration the inclusion and exclusion criteria, patients whose having different types of age-related Macular Degeneration (ARMD) and their ocular problems operated in Department of Ophthalmology, M. P. Shah medical college, Jamnagar between December 2021 to June 2022 at our institute observed for study. Result: We enrolled 200 patients with Age related macular degeneration patients who visiting at our OPD centre. In our study population, the highest percentage observed in the age group of 66- 75 years age group. Female predominance was seen. Dry ARMD was significantly higher in females compared to males. Conclusion: In the coming years, ARMD will become an important cause of vision loss in India due to ageing population because of better longevity.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
569 Views
457 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved